Literature DB >> 22395698

The AKTion in non-canonical insulin signaling.

Zhiyong Cheng, Morris F White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22395698      PMCID： PMC3982803          DOI： 10.1038/nm.2694

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  15 in total

1.  Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action.

Authors:  Varman T Samuel; Cheol Soo Choi; Trevor G Phillips; Anthony J Romanelli; John G Geisler; Sanjay Bhanot; Robert McKay; Brett Monia; John R Shutter; Richard A Lindberg; Gerald I Shulman; Murielle M Veniant
Journal:  Diabetes       Date:  2006-07       Impact factor: 9.461

2.  Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver.

Authors:  Michihiro Matsumoto; Alessandro Pocai; Luciano Rossetti; Ronald A Depinho; Domenico Accili
Journal:  Cell Metab       Date:  2007-09       Impact factor: 27.287

3.  Metformin and insulin meet in a most atypical way.

Authors:  Morris F White
Journal:  Cell Metab       Date:  2009-06       Impact factor: 27.287

Review 4.  PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure.

Authors:  Carles Cantó; Johan Auwerx
Journal:  Curr Opin Lipidol       Date:  2009-04       Impact factor: 4.776

5.  Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein.

Authors:  Xiao Yan Zhou; Nobuyuki Shibusawa; Karuna Naik; Delia Porras; Karla Temple; Hesheng Ou; Kelly Kaihara; Michael W Roe; Matthew J Brady; Fredric E Wondisford
Journal:  Nat Med       Date:  2004-05-16       Impact factor: 53.440

6.  Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein.

Authors:  Ling He; Amin Sabet; Stephen Djedjos; Ryan Miller; Xiaojian Sun; Mehboob A Hussain; Sally Radovick; Fredric E Wondisford
Journal:  Cell       Date:  2009-05-15       Impact factor: 41.582

7.  Inactivation of hepatic Foxo1 by insulin signaling is required for adaptive nutrient homeostasis and endocrine growth regulation.

Authors:  Xiaocheng C Dong; Kyle D Copps; Shaodong Guo; Yedan Li; Ramya Kollipara; Ronald A DePinho; Morris F White
Journal:  Cell Metab       Date:  2008-07       Impact factor: 27.287

Review 8.  Selective versus total insulin resistance: a pathogenic paradox.

Authors:  Michael S Brown; Joseph L Goldstein
Journal:  Cell Metab       Date:  2008-02       Impact factor: 27.287

9.  Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis.

Authors:  Robert K Semple; Alison Sleigh; Peter R Murgatroyd; Claire A Adams; Les Bluck; Sarah Jackson; Alessandra Vottero; Dipak Kanabar; Valentine Charlton-Menys; Paul Durrington; Maria A Soos; T Adrian Carpenter; David J Lomas; Elaine K Cochran; Phillip Gorden; Stephen O'Rahilly; David B Savage
Journal:  J Clin Invest       Date:  2009-01-26       Impact factor: 14.808

10.  A family with severe insulin resistance and diabetes due to a mutation in AKT2.

Authors:  Stella George; Justin J Rochford; Christian Wolfrum; Sarah L Gray; Sven Schinner; Jenny C Wilson; Maria A Soos; Peter R Murgatroyd; Rachel M Williams; Carlo L Acerini; David B Dunger; David Barford; A Margot Umpleby; Nicholas J Wareham; Huw Alban Davies; Alan J Schafer; Markus Stoffel; Stephen O'Rahilly; Inês Barroso
Journal:  Science       Date:  2004-05-28       Impact factor: 47.728
View more
  13 in total

Review 1.  Cooperation between brain and islet in glucose homeostasis and diabetes.

Authors:  Michael W Schwartz; Randy J Seeley; Matthias H Tschöp; Stephen C Woods; Gregory J Morton; Martin G Myers; David D'Alessio
Journal:  Nature       Date:  2013-11-07       Impact factor: 49.962

2.  Neuronal overexpression of insulin receptor substrate 2 leads to increased fat mass, insulin resistance, and glucose intolerance during aging.

Authors:  J Zemva; M Udelhoven; L Moll; S Freude; O Stöhr; H S Brönneke; R B Drake; W Krone; M Schubert
Journal:  Age (Dordr)       Date:  2012-11-17

3.  FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization.

Authors:  InSug O-Sullivan; Wenwei Zhang; David H Wasserman; Chong Wee Liew; Jonathan Liu; Jihye Paik; Ronald A DePinho; Donna Beer Stolz; C Ronald Kahn; Michael W Schwartz; Terry G Unterman
Journal:  Nat Commun       Date:  2015-05-12       Impact factor: 14.919

4.  FoxO1 antagonist suppresses autophagy and lipid droplet growth in adipocytes.

Authors:  Longhua Liu; Louise D Zheng; Peng Zou; Joseph Brooke; Cayleen Smith; Yun Chau Long; Fabio A Almeida; Dongmin Liu; Zhiyong Cheng
Journal:  Cell Cycle       Date:  2016-06-03       Impact factor: 4.534

Review 5.  Diabetic cardiomyopathy and metabolic remodeling of the heart.

Authors:  Pavan K Battiprolu; Camila Lopez-Crisosto; Zhao V Wang; Andriy Nemchenko; Sergio Lavandero; Joseph A Hill
Journal:  Life Sci       Date:  2012-10-30       Impact factor: 5.037

6.  Therapeutic effects of in vivo-differentiated stem cell and Matricaria chamomilla L. Oil in diabetic rabbit.

Authors:  Afsaneh Fazili; Soghra Gholami; Mojgan Sheikhpour; Pegah Pousti
Journal:  J Diabetes Metab Disord       Date:  2020-05-11

7.  Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo.

Authors:  Paul M Titchenell; Qingwei Chu; Bobby R Monks; Morris J Birnbaum
Journal:  Nat Commun       Date:  2015-05-12       Impact factor: 14.919

8.  Direct control of hepatic glucose production by interleukin-13 in mice.

Authors:  Kristopher J Stanya; David Jacobi; Sihao Liu; Prerna Bhargava; Lingling Dai; Matthew R Gangl; Karen Inouye; Jillian L Barlow; Yewei Ji; Joseph P Mizgerd; Ling Qi; Hang Shi; Andrew N J McKenzie; Chih-Hao Lee
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

9.  Targeting FoxO1 with AS1842856 suppresses adipogenesis.

Authors:  Peng Zou; Longhua Liu; Louise Zheng; Lu Liu; Rebecca E Stoneman; Alicia Cho; Ashley Emery; Elizabeth R Gilbert; Zhiyong Cheng
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

10.  Benzylglucosinolate Derived Isothiocyanate from Tropaeolum majus Reduces Gluconeogenic Gene and Protein Expression in Human Cells.

Authors:  Valentina Guzmán-Pérez; Christiane Bumke-Vogt; Monika Schreiner; Inga Mewis; Andrea Borchert; Andreas F H Pfeiffer
Journal:  PLoS One       Date:  2016-09-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.